Products

Providing Excellent Products in High-value Consumables and Medical Equipment

Reconeer® Transjugular Intrahepatic Puncture Biopsy Kit

The Reconeer® Transjugular Intrahepatic Puncture Biopsy Kit involves insertion of a catheter through the jugular vein, creation of a venous channel through a guide, and delivery of a biopsy needle into the liver, ultimately obtaining liver histopathology.

EqualSpheres Narrow-size Embolic Microspheres

Launched in 2021, EqualSpheres<sup>®</sup> Narrow-size Embolic Microspheres incorporates patented technology and has obtained approvals from both the China NMPA and the USA FDA (510k). It is intended to be used for the embolization of arteriovenous malformations (AVMs) and hyper vascular tumors, including uterine fibroids. So far, it’s successfully deployed in thousands of hospitals and primarily employed for the embolization treatment of various solid malignant tumors, including primary liver cancer, metastatic liver cancer, lung cancer, kidney cancer, cervical cancer, prostate cancer, and soft tissue sarcoma.

EvenSpheres Narrow-size Embolic Microspheres

Launched in 2021, EvenSpheres<sup>®</sup> Narrow-size Embolic Microspheres incorporates patented technology and has obtained approvals from both the China NMPA and the USA FDA (510k). It is intended to be used for the embolization of arteriovenous malformations (AVMs) and hyper vascular tumors, including uterine fibroids. So far, it’s successfully deployed in thousands of hospitals and primarily employed for the embolization treatment of various solid malignant tumors, including primary liver cancer, metastatic liver cancer, lung cancer, kidney cancer, cervical cancer, prostate cancer, and soft tissue sarcoma.

CalliSpheres Embolic Microspheres

Launched in 2015, CalliSpheres<sup>®</sup> Embolic Microspheres incorporates patented technology and has obtained approvals from both the China NMPA and the USA FDA (510k). It is intended to be used for the embolization of arteriovenous malformations (AVMs) and hyper vascular tumors, including uterine fibroids. So far, it’s successfully deployed in thousands of hospitals and primarily employed for the embolization treatment of various solid malignant tumors, including primary liver cancer, metastatic liver cancer, lung cancer, kidney cancer, cervical cancer, prostate cancer, and soft tissue sarcoma.

8Spheres Embolic Microspheres

Launched in 2015, 8Spheres<sup>®</sup> Embolic Microspheres incorporates patented technology and has obtained approvals from both the China NMPA and the USA FDA (510k). It is intended to be used for the embolization of arteriovenous malformations (AVMs) and hyper vascular tumors, including uterine fibroids. So far, it’s successfully deployed in thousands of hospitals and primarily employed for the embolization treatment in benign conditions such as hemoptysis, splenomegaly, uterine fibroids, adenomyosis, and benign prostatic hyperplasia.

RAPIDTHRU DA Micro Catheter and Guidewire System

The RAPIDTHRU<sup>®</sup> DA Micro Catheter and Guidewire System is intended for infusing contrast media into the peripheral vasculature and for drug infusion in intra-arterial therapy, as well as for the infusion of embolic materials for hemostasis. It represents an upgraded version of the RAPIDTHRU<sup>®</sup>, with significant improvements in product specifications, contrast performance, and torque ability.

VenousRF Endovenous Radiofrequency Ablation System

VenousRF<sup>®</sup> Radiofrequency Ablation System consist of the VenousRF<sup>®</sup> 100 radiofrequency generator and Sapheuns®6F80 radiofrequency disclosure catheters. The system is intended for the treatment of varicose veins in the main trunk and communicating branch of the lower limb's great saphenous vein. This minimally invasive procedure uses controlled heat from radiofrequency waves to close and seal problematic veins. A catheter with an RF electrode is guided into the affected vein for the ablation, commonly addressing varicose veins.

MaxWave Microwave Ablation System

MaxWave<sup>®</sup> Microwave Ablation System consist of MaxWave<sup>®</sup>150 microwave ablation generator and Minbolt disposal microwave ablation antennas. It primarily utilizes microwave energy to heat tissues to high temperatures, aiming to achieve the ablation or coagulation of abnormal tissues. The system is intended for the ablation (coagulation) of soft tissue, particularly for the partial or complete ablation of non-resectable liver tumors. Additionally, many doctors and medical institutions use it for the treatment of lung cancer, kidney cancer, or thyroid cancer, kidney cancer, or thyroid cancer.